India  
 
NewsR.in

Bharat Biotech stresses on Covaxin’s safety record after AstraZeneca admits to Covishield causing rare clotting side effects

IndiaTimes Thursday, 2 May 2024
Following AstraZeneca's acknowledgment in a UK court that its Covid-19 vaccine triggered a rare side effect—Thrombosis with Thrombocytopenia Syndrome (TTS), Hyderabad-based vaccine manufacturer Bharat Biotech emphasized the safety of its indigenous vaccine, Covaxin, aiming to alleviate public apprehensions regarding Covid vaccines. AstraZeneca’s vaccine Vaxzevria, which it developed in collaboration with Oxford University, was manufactured under the Covishield brandname in India.
0
shares		ShareTweetSavePostSend
 
Video Credit: Oneindia - Published
News video: Covishield: Parents File Lawsuit Against Serum Institute Amid AstraZeneca’s Report| Oneindia

Covishield: Parents File Lawsuit Against Serum Institute Amid AstraZeneca’s Report| Oneindia 03:03

 After AstraZeneca's acknowledgment of rare side effects, parents of a woman allegedly deceased post-Covishield vaccination initiated legal action against Serum Institute of India. Covishield, developed by AstraZeneca and Oxford University, faced scrutiny. Another family shared the plight of their...

You Might Like


Related videos from verified sources

AstraZeneca and deadly “rare” blood clots - it ISN'T only AstraZeneca they are anything BUT rare.. [Video]

AstraZeneca and deadly “rare” blood clots - it ISN'T only AstraZeneca they are anything BUT rare..

AstraZeneca and deadly “rare” blood clots I can tell you - it ISN'T only AstraZeneca and they are anything BUT rare..

Credit: Rumble     Duration: 00:43Published
AstraZeneca Withdraws COVID-19 Vaccine Globally, Days After Side Effect Confession in UK Court [Video]

AstraZeneca Withdraws COVID-19 Vaccine Globally, Days After Side Effect Confession in UK Court

AstraZeneca has globally withdrawn its Covid vaccine, citing commercial reasons. The company voluntarily revoked its marketing authorization and announced the cessation of vaccine production, rendering..

Credit: Oneindia     Duration: 05:11Published
Political uproar in India after Astrazeneca admits blood clot side effect [Video]

Political uproar in India after Astrazeneca admits blood clot side effect

A political controversy has erupted in India after British pharma giant Astrazeneca admitted in the UK court that it's Covid-19 vaccine to blood clots in "very rare cases"...

Credit: Rumble     Duration: 06:02Published

Related news from verified sources

AstraZeneca reaffirms COVID-19 vaccine Covishield safety amidst rare side effect concerns

 In light of recent concerns surrounding potential rare side effects of the AstraZeneca-Oxford COVID-19 vaccine, the pharmaceutical giant has reiterated its...
DNA